These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11803465)

  • 1. Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis.
    Zhang YW; Wang LM; Jove R; Vande Woude GF
    Oncogene; 2002 Jan; 21(2):217-26. PubMed ID: 11803465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
    Jeffers M; Rong S; Anver M; Vande Woude GF
    Oncogene; 1996 Aug; 13(4):853-6. PubMed ID: 8761307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the c-Met receptor complex in fibroblasts drives invasive cell behavior by signaling through transcription factor STAT3.
    Cramer A; Kleiner S; Westermann M; Meissner A; Lange A; Friedrich K
    J Cell Biochem; 2005 Jul; 95(4):805-16. PubMed ID: 15838885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
    Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HGF/SF-met signaling in the control of branching morphogenesis and invasion.
    Zhang YW; Vande Woude GF
    J Cell Biochem; 2003 Feb; 88(2):408-17. PubMed ID: 12520544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas.
    Hecht M; Papoutsi M; Tran HD; Wilting J; Schweigerer L
    Cancer Res; 2004 Sep; 64(17):6109-18. PubMed ID: 15342394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor induces delayed STAT3 phosphorylation through interleukin-6 expression.
    Lee BS; Park M; Cha HY; Lee JH
    Cell Signal; 2009 Mar; 21(3):419-27. PubMed ID: 19071214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Met and hepatocyte growth factor/scatter factor expression in human gliomas.
    Koochekpour S; Jeffers M; Rulong S; Taylor G; Klineberg E; Hudson EA; Resau JH; Vande Woude GF
    Cancer Res; 1997 Dec; 57(23):5391-8. PubMed ID: 9393765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA; Merlino G
    Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased fibronectin expression in Met/HGF-mediated tumorigenesis.
    Taylor GA; Jeffers M; Webb CP; Koo HM; Anver M; Sekiguchi K; Vande Woude GF
    Oncogene; 1998 Sep; 17(9):1179-83. PubMed ID: 9764829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
    Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L; Turkson J; Karras JG; Jove R; Haura EB
    Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models.
    Cao B; Su Y; Oskarsson M; Zhao P; Kort EJ; Fisher RJ; Wang LM; Vande Woude GF
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7443-8. PubMed ID: 11416216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA; Merlino G
    Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A.
    Cacci E; Salani M; Anastasi S; Perroteau I; Poiana G; Biagioni S; Augusti-Tocco G
    J Neurosci Res; 2003 Dec; 74(5):760-8. PubMed ID: 14635227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
    Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor expression in human cancer and therapy with specific inhibitors.
    Haddad R; Lipson KE; Webb CP
    Anticancer Res; 2001; 21(6B):4243-52. PubMed ID: 11908677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 activation is required for interleukin-6 induced transformation in tumor-promotion sensitive mouse skin epithelial cells.
    Yu CY; Wang L; Khaletskiy A; Farrar WL; Larner A; Colburn NH; Li JJ
    Oncogene; 2002 Jun; 21(25):3949-60. PubMed ID: 12037677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis.
    Lee CC; Putnam AJ; Miranti CK; Gustafson M; Wang LM; Vande Woude GF; Gao CF
    Oncogene; 2004 Jul; 23(30):5193-202. PubMed ID: 15122328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.